Presidio Pharamceuticals is a specialty pharma company focused on the development of therapeutics for viral infections, including HCV and HIV.
Presidio Pharmaceuticals
Organization
Address
Facts from the Community
From the BioVenturist base
Technology Focus:
Investment Round:
| Amount raised | Currency | Date | Investors |
|---|---|---|---|
|
|
We can also tell you Presidio Pharmaceuticals is a
If you know more about Presidio Pharmaceuticals, you can add more facts here »
Similar topics in Freebase
-
Dendreon
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells (autologous, with dendritic cells thought to be the most important)... -
QLT Inc.
-
Alnara Pharmaceuticals Inc.
Alnara is developing non-systemic protein therapeutics for metabolic and inflammatory diseases. -
UCB
UCB (Union chimique belge) is a multinational biopharmaceutical manufacturing company headquartered in Brussels, Belgium. Every 3 years, the company presents the UCB Award under the patronage of the Queen Elizabeth Medical Foundation to promote neuroscience research. The winner of this award is... -
Johnson & Johnson
Johnson & Johnson (NYSE: JNJ) is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson consistently... -
InfaCare Pharmaceutical Corp
InfaCare is developing therapeutics for acute care infant/pediatric patients.